Strata Critical Medical Ord Shs Class A
SRTA4.944USD
+0.324+7.00%
Market hours （ET）Quotes delayed by 15 min
425.39MMarket Cap
10.04P/E TTM
More Details of Company
Strata Critical Medical Ord Shs Class A Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Strata Critical Medical Ord Shs Class A
Name
Name/Position
Position
Shareholding
Change
Mr. Robert S. Wiesenthal
Mr. Robert S. Wiesenthal
Chief Executive Officer, Director
Chief Executive Officer, Director
5.11M
+9.26%
Mr. William A. Heyburn
Mr. William A. Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Head of Corporate Development, Director
Co-Chief Executive Officer, Chief Financial Officer, Head of Corporate Development, Director
965.60K
-9.40%
Mr. Eric L. Affeldt
Mr. Eric L. Affeldt
Independent Chairman of the Board
Independent Chairman of the Board
581.21K
+6.51%
Mr. Scott M. Wunsch
Mr. Scott M. Wunsch
Chief Executive Officer - Trinity
Chief Executive Officer - Trinity
315.04K
+4.44%
Mr. Edward M. (Ted) Philip
Mr. Edward M. (Ted) Philip
Independent Director
Independent Director
234.16K
+17.89%
Ms. Susan M. Lyne
Ms. Susan M. Lyne
Independent Director
Independent Director
187.19K
+23.43%
Mr. Reginald L. Love
Mr. Reginald L. Love
Independent Director
Independent Director
113.90K
-16.19%
Mr. Andrew C. Lauck
Mr. Andrew C. Lauck
Independent Director
Independent Director
--
--
Mr. John Kl Borthwick
Mr. John Kl Borthwick
Independent Director
Independent Director
--
--
Mr. Amir M. Cohen
Mr. Amir M. Cohen
Chief Accounting Officer
Chief Accounting Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert S. Wiesenthal
Mr. Robert S. Wiesenthal
Chief Executive Officer, Director
Chief Executive Officer, Director
5.11M
+9.26%
Mr. William A. Heyburn
Mr. William A. Heyburn
Co-Chief Executive Officer, Chief Financial Officer, Head of Corporate Development, Director
Co-Chief Executive Officer, Chief Financial Officer, Head of Corporate Development, Director
965.60K
-9.40%
Mr. Eric L. Affeldt
Mr. Eric L. Affeldt
Independent Chairman of the Board
Independent Chairman of the Board
581.21K
+6.51%
Mr. Scott M. Wunsch
Mr. Scott M. Wunsch
Chief Executive Officer - Trinity
Chief Executive Officer - Trinity
315.04K
+4.44%
Mr. Edward M. (Ted) Philip
Mr. Edward M. (Ted) Philip
Independent Director
Independent Director
234.16K
+17.89%
Ms. Susan M. Lyne
Ms. Susan M. Lyne
Independent Director
Independent Director
187.19K
+23.43%
Revenue Breakdown
Currency: USDUpdated: Tue, Dec 9
Currency: USDUpdated: Tue, Dec 9
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Other
45.11M
63.71%
Short Distance
17.20M
24.29%
MediMobility Organ Transport and Jet
8.50M
12.00%
By RegionUSD
Name
Revenue
Proportion
United States
62.45M
88.20%
Others
8.36M
11.80%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Other
45.11M
63.71%
Short Distance
17.20M
24.29%
MediMobility Organ Transport and Jet
8.50M
12.00%
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
KSL Capital Partners, LLC
9.17%
ARK Investment Management LLC
7.42%
Wiesenthal (Robert S)
5.92%
Third Point LLC
5.79%
BlackRock Institutional Trust Company, N.A.
4.52%
Other
67.19%
Shareholders
Shareholders
Proportion
KSL Capital Partners, LLC
9.17%
ARK Investment Management LLC
7.42%
Wiesenthal (Robert S)
5.92%
Third Point LLC
5.79%
BlackRock Institutional Trust Company, N.A.
4.52%
Other
67.19%
Shareholder Types
Shareholders
Proportion
Investment Advisor
25.78%
Investment Advisor/Hedge Fund
21.87%
Individual Investor
12.41%
Hedge Fund
10.39%
Private Equity
9.17%
Research Firm
1.94%
Bank and Trust
0.16%
Pension Fund
0.08%
Family Office
0.04%
Other
18.16%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
264
59.95M
69.42%
-3.46M
2025Q3
272
59.95M
69.42%
-3.80M
2025Q2
257
56.02M
67.63%
-3.26M
2025Q1
254
55.27M
67.51%
-4.54M
2024Q4
258
56.51M
71.24%
-903.43K
2024Q3
255
57.39M
73.17%
+1.60M
2024Q2
255
51.40M
66.14%
-3.16M
2024Q1
249
50.26M
65.33%
-3.50M
2023Q4
251
49.24M
66.45%
-4.14M
2023Q3
259
47.40M
64.51%
-5.17M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
KSL Capital Partners, LLC
7.92M
9.17%
--
--
Mar 13, 2025
ARK Investment Management LLC
6.40M
7.42%
-2.20M
-25.52%
Sep 30, 2025
Wiesenthal (Robert S)
5.11M
5.92%
+433.24K
+9.26%
Aug 29, 2025
Third Point LLC
5.00M
5.79%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.90M
4.52%
+24.43K
+0.63%
Sep 30, 2025
The Vanguard Group, Inc.
3.38M
3.91%
+81.14K
+2.46%
Sep 30, 2025
DigitalBridge Group, Inc.
3.35M
3.87%
+3.35M
--
Jul 12, 2024
Amova Asset Management Americas, Inc
2.84M
3.29%
-679.33K
-19.30%
Jun 30, 2025
AWM Investment Company, Inc.
2.82M
3.27%
+56.00K
+2.02%
Sep 30, 2025
Amova Asset Management Co., Ltd.
1.83M
2.12%
-1.17M
-39.03%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
ARK Space & Defense Innovation ETF
1.71%
ARK Autonomous Technology & Robotics ETF
1.15%
State Street SPDR S&P Kensho Smart Mobility ETF
0.42%
iShares Micro-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.04%
Vanguard US Momentum Factor ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Value ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
View more
ARK Space & Defense Innovation ETF
Proportion1.71%
ARK Autonomous Technology & Robotics ETF
Proportion1.15%
State Street SPDR S&P Kensho Smart Mobility ETF
Proportion0.42%
iShares Micro-Cap ETF
Proportion0.05%
Avantis US Small Cap Equity ETF
Proportion0.04%
Vanguard US Momentum Factor ETF
Proportion0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.02%
iShares Russell 2000 Value ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Strata Critical Medical Ord Shs Class A?
The top five shareholders of Strata Critical Medical Ord Shs Class A are:
KSL Capital Partners, LLC holds 7.92M shares, accounting for 9.17% of the total shares.
ARK Investment Management LLC holds 6.40M shares, accounting for 7.42% of the total shares.
Wiesenthal (Robert S) holds 5.11M shares, accounting for 5.92% of the total shares.
Third Point LLC holds 5.00M shares, accounting for 5.79% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.90M shares, accounting for 4.52% of the total shares.
KSL Capital Partners, LLC holds 7.92M shares, accounting for 9.17% of the total shares.
ARK Investment Management LLC holds 6.40M shares, accounting for 7.42% of the total shares.
Wiesenthal (Robert S) holds 5.11M shares, accounting for 5.92% of the total shares.
Third Point LLC holds 5.00M shares, accounting for 5.79% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.90M shares, accounting for 4.52% of the total shares.
What are the top three shareholder types of Strata Critical Medical Ord Shs Class A?
The top three shareholder types of Strata Critical Medical Ord Shs Class A are:
KSL Capital Partners, LLC
ARK Investment Management LLC
Wiesenthal (Robert S)
KSL Capital Partners, LLC
ARK Investment Management LLC
Wiesenthal (Robert S)
How many institutions hold shares of Strata Critical Medical Ord Shs Class A (SRTA)?
As of 2025Q4, 264 institutions hold shares of Strata Critical Medical Ord Shs Class A, with a combined market value of approximately 59.95M, accounting for 69.42% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.00%.
What is the biggest source of revenue for Strata Critical Medical Ord Shs Class A?
In FY2025Q2, the Other business generated the highest revenue for Strata Critical Medical Ord Shs Class A, amounting to 45.11M and accounting for 63.71% of total revenue.
